The Genome Project
To decipher genetic codes that form tumours
Our research over the last 10 years has led to the identification of new biomarkers which has allowed patients to receive better and safer diagnoses of bone tumours. These new biomarkers also allow selection of some patients for new treatments which is needed as survival of patient with bone cancer has not changed significantly in the last 30 years.
Over the next 12 months we aim to provide more insight into how tumours develop and how they may be better treated.
This is exciting, ground breaking science and with the funding received from SCAT the pathologists at the RNOH have led the genetic classification of bone tumours across the world.
The research has allowed patients whose tumours have specific genetic alterations potentially to be recruited into clinical trials. This offers selected patients opportunities for new treatments.